Small airways morphological alterations associated with functional impairment in lymphangioleiomyomatosis

Imagem de Miniatura
Arquivos
art_MENDONCA_Small_airways_morphological_alterations_associated_with_functional_impairment_2024.PDF (2.98 MB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
Citação
BMC PULMONARY MEDICINE, v.24, n.1, article ID 22, 11p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundLymphangioleiomyomatosis (LAM) is a rare neoplastic and cystic pulmonary disease characterized by abnormal proliferation of the so-called LAM cells. Despite the functional obstructive pattern observed in most patients, few studies investigated the morphological changes in the small airways, most of them in patients with severe and advanced LAM undergoing lung transplantation. Understanding the morphological changes in the airways that may occur early in the disease can help us understand the pathophysiology of disease progression and understand the rationale for possible therapeutic approaches, such as the use of bronchodilators. Our study aimed to characterize the morphological alterations of the small airways in patients with LAM with different severities compared to controls, and their association with variables at the pulmonary function test and with LAM Histological Score (LHS).MethodsThirty-nine women with LAM who had undergone open lung biopsy or lung transplantation, and nine controls were evaluated. The histological severity of the disease was assessed as LHS, based on the percentage of tissue involvement by cysts and infiltration by LAM cells. The following morphometric parameters were obtained: airway thickness, airway closure index, collagen and airway smooth muscle content, airway epithelial TGF-beta expression, and infiltration of LAM cells and inflammatory cells within the small airway walls.ResultsThe age of patients with LAM was 39 +/- 8 years, with FEV1 and DLCO of 62 +/- 30% predicted and 62 +/- 32% predicted, respectively. Patients with LAM had increased small airway closure index, collagen and smooth muscle content, and epithelial TGF-beta expression compared with controls. Patients with LAM with the more severe LHS and with greater functional severity (FEV1 <= 30%) presented higher thicknesses of the airways. Bronchiolar inflammation was mild; infiltration of the small airway walls by LAM cells was rare. LHS was associated with an obstructive pattern, air trapping, and reduced DLCO, whereas small airway wall thickness was associated with FEV1, FVC, and collagen content.ConclusionLAM is associated with small airway remodelling and partial airway closure, with structural alterations observed at different airway compartments. Functional impairment in LAM is associated with airway remodelling and, most importantly, with histological severity (LHS).
Palavras-chave
Lymphangioleiomyomatosis, Small airways, Pulmonary function test, LAM Score, Immunohistochemistry
URI
https://observatorio.fm.usp.br/handle/OPI/57907
Referências
  1. Aubry MC, 2000, AM J RESP CRIT CARE, V162, P749, DOI 10.1164/ajrccm.162.2.9911006
  2. Cohen MM, 2005, THORAX, V60, P875, DOI 10.1136/thx.2004.035154
  3. CORRIN B, 1975, AM J PATHOL, V79, P348
  4. Cudzilo CJ, 2013, CHEST, V144, P578, DOI 10.1378/chest.12-2813
  5. Evans SE, 2004, CHEST, V125, P1063, DOI 10.1378/chest.125.3.1063
  6. Glassberg MK, 2004, CLIN CHEST MED, V25, P573, DOI 10.1016/j.ccm.2004.05.003
  7. Grzegorek I, 2015, ANTICANCER RES, V35, P3353
  8. Baldi BG, 2014, SARCOIDOSIS VASC DIF, V31, P129
  9. Harknett EC, 2011, QJM-INT J MED, V104, P971, DOI 10.1093/qjmed/hcr116
  10. Hayashi T, 2016, HUM PATHOL, V50, P34, DOI 10.1016/j.humpath.2015.11.002
  11. JAMES AL, 1988, AM REV RESPIR DIS, V138, P136, DOI 10.1164/ajrccm/138.1.136
  12. James AL, 2008, J APPL PHYSIOL, V104, P1703, DOI 10.1152/japplphysiol.00169.2008
  13. Johnson SR, 2000, THORAX, V55, P1052, DOI 10.1136/thorax.55.12.1052
  14. Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283
  15. Matsui K, 2001, AM J SURG PATHOL, V25, P479, DOI 10.1097/00000478-200104000-00007
  16. Matsushita MD, 2005, J PATHOL, V207, P102, DOI 10.1002/path.1818
  17. Medeiros Junior Pedro, 2004, J. bras. pneumol., V30, P66, DOI 10.1590/S1806-37132004000100013
  18. Miller S, 2020, J PATHOL CLIN RES, V6, P215, DOI 10.1002/cjp2.162
  19. Neder JA, 1999, BRAZ J MED BIOL RES, V32, P729, DOI 10.1590/S0100-879X1999000600008
  20. Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006
  21. Oprescu N, 2013, LUNG, V191, P35, DOI 10.1007/s00408-012-9419-3
  22. Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008
  23. Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC
  24. Sathirareuangchai S, 2001, Surg Exp Pathol, V4
  25. SOBONYA RE, 1985, HUM PATHOL, V16, P1122, DOI 10.1016/S0046-8177(85)80180-5
  26. Sociedade Brasileira de Pneumologia e Tisiologia, 2002, J Pneumol, V28, P1
  27. Taveira-DaSilva AM, 2001, AM J RESP CRIT CARE, V164, P1072, DOI 10.1164/ajrccm.164.6.2102125
  28. Taveira-DaSilva AM, 2010, LYMPHAT RES BIOL, V8, P9, DOI 10.1089/lrb.2009.0024
  29. TAYLOR JR, 1990, NEW ENGL J MED, V323, P1254, DOI 10.1056/NEJM199011013231807
  30. do Nascimento ECT, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0797-9
  31. Verleden SE, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01965-2019
  32. Yu J, 2001, AM J RESP CRIT CARE, V164, P1537, DOI 10.1164/ajrccm.164.8.2104095

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/05
Artigos e Materiais de Revistas Científicas - LIM/09
Carregar mais